drugset / Trial / NCT07138274
Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
RandomizedParallel-groupDouble-blindTreatment
Summary
single-center, randomized, double-blind, placebo-controlled Phase 2 study to evaluate safety and efficacy of overnight metyrapone in patients with MACS.
Timeline
- Start
- 2026-10
- Primary completion
- 2031-06
- Completion
- 2031-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metyrapone | Small molecule | 1000 mg | Oral |